[Congressional Record Volume 154, Number 106 (Wednesday, June 25, 2008)]
[Extensions of Remarks]
[Page E1351]
From the Congressional Record Online through the Government Publishing Office [www.gpo.gov]




  RECOGNIZING THE CONTRIBUTIONS OF GRIFOLS USA TO LOS ANGELES AND THE 
                             UNITED STATES.

                                  _____
                                 

                          HON. HILDA L. SOLIS

                             of california

                    in the house of representatives

                        Wednesday, June 25, 2008

  Ms. SOLIS. Madam Speaker, I rise today to recognize the contributions 
of Grifols USA to my community and other communities across the 
country.
  This Friday will mark 5 years since Grifols USA began operating its 
facility in East Los Angeles. That is 5 years of over 600 jobs for 
residents of East Los Angeles and the surrounding area. Furthermore, 
Grifols' steady growth and expansion will continue to present 
additional opportunities to my constituents for years to come, and well 
into the future.
  Grifols' prosperity has positively impacted many communities, not 
just my district. Currently, Grifols operates 78 plasma donor 
facilities, in 27 States across the country, which provide skilled and 
entry-level employment opportunities to over 3,000 Americans.
  Perhaps more praiseworthy than Grifols' economic contributions 
though, is the company's mission. I would like to honor Grifols for its 
commitment to producing unique, lifesaving medicines to treat small, 
chronically ill patient populations. The company's unwavering 
dedication to the development of safer, more effective plasma 
therapies, and progressing methods, has been a benefit to countless 
patients around the world who suffer from a number of disorders.
  Madam Speaker, I ask my colleagues to join me in recognizing Grifols 
for the company's positive presence in many of our Nation's communities 
and tireless commitment to improve the lives of patients with chronic 
illnesses.




                          ____________________